Mirus Capital AdvisorsMirus Capital Advisors

Mirus Advises BioPharm Engineered Systems, Inc. in Sale to Critical Process Systems Group

Mirus Capital Advisors announced that BioPharm Engineered Systems, Inc. (“BPES”), a leading provider of custom process equipment to the biopharmaceutical and pharmaceutical industries, located in Andover, Massachusetts, has been acquired by Critical Process Systems Group of Colchester, Vermont.  Mirus served as the exclusive financial advisor to the shareholders of BPES in arranging the transaction.

“After 9 years building BPES’s position as a quality leader of custom process equipment to the biopharmaceutical industry, I wanted to transition the company to owners who see and can take advantage of the market opportunities arising from our participation in this fast-growing industry,” said Joe Norton, founder and shareholder of BPES.  “The Mirus team successfully guided us through every aspect of the transaction, from identifying prospective buyers through closing. They conducted a thorough process and we are delighted by the outcome for BPES, its management team, and its shareholders.”

About BioPharm Engineered Systems, Inc.

BioPharm has an experienced in-house design and fabrication team that delivers systems on time and on budget around the world.  Systems are designed with the goal of maximizing product recovery and with ease of operating and maintaining.  Paul Brouillette, President of BPES, stated “we are very excited about the acquisition by the CPS Group.  Their corporate resources and our new sister company CPS Process Solutions will certainly allow BPES to better support existing customers, gain new business and expand our product offerings.”

About Critical Process Systems Group

Critical Process Systems Group is a family of manufacturing and design companies focused on providing innovative product solutions to the life science, semiconductor, renewable energy, chemical processing, and general industrial markets.  Paul Frascoia, CEO of Critical Process Systems Group stated “we are pleased to add BPES to our family of companies.  We believe that their capabilities, product offerings and excellent market reputation align perfectly with our effort to expand our market presence in the growing biotech and pharmaceutical markets.

About Mirus Capital Advisors

Mirus Capital Advisors provides investment banking solutions to business owners in technology, business services, manufacturing, consumer products, health care and the resort & hospitality industry. Since 1987, Mirus has provided corporate finance advisory services on engagements including mergers, acquisitions, divestitures, recapitalizations and valuations.

Back to Transactions